Persistent thrombocytopenia following dengue shock syndrome

Indian Journal of Pediatrics

Volumn 75, Issue 1, 2008, Pages 82-83

  Kohli, Utkarsh ^a   Saharan, Sunil ^a   Lodha, Rakesh ^a   Kabra, S K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Dengue shock syndrome; Thrombocytopenia

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID; RINGER LACTATE SOLUTION; GLUCOCORTICOID; ISOTONIC SOLUTION; RINGER'S LACTATE; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; BONE MARROW BIOPSY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DENGUE; DENGUE SHOCK SYNDROME; EXTUBATION; HEMATOCRIT; HUMAN; HUMAN TISSUE; INTUBATION; LABORATORY TEST; NEUROLOGIC EXAMINATION; SCHOOL CHILD; SHOCK; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TOURNIQUET; CHILD; DRUG COMBINATION; FATALITY; MALE; THROMBOCYTE RICH PLASMA; VIROLOGY;

ADRENAL CORTEX HORMONES; CHILD; DENGUE HEMORRHAGIC FEVER; DRUG THERAPY, COMBINATION; FATAL OUTCOME; GLUCOCORTICOIDS; HUMANS; ISOTONIC SOLUTIONS; MALE; PLATELET-RICH PLASMA; RESPIRATORY DISTRESS SYNDROME, ADULT; THROMBOCYTOPENIA;

EID: 42449145635     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-008-0014-9     Document Type: Article

References (10)

1. Rigau-Perez JG, Clark GC, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue hemorrhagic fever. Lancet 1998; 352: 971-977.
2. Ratageri VH, Shepur TA, Wari PK, Chavan SC, Mujahid IB, Yergolkar P. Clinical profile and outcome of dengue fever cases. Indian J Pediatr 2005; 72: 705-706.
3. Kamil SM, Mohamad NH, Narazah MY, Khan FA. Dengue hemorrhagic fever with unusual prolonged thrombocytopenia. Singapore Med J 2006; 47: 332-334.
4. Leong KW, Srinivas P. Corticosteroid-responsive prolonged thrombocytopenia following dengue hemorrhagic fever. Med J Malaysia 1993; 48: 369-372.
5. Nimmannitya S. Clinical manifestations of dengue/dengue hemorrhagic fever. In Monograph on dengue/dengue hemorrhagic fever. New Delhi; World Health Organization, 1993;48-54.
6. Saito M, Oishi K, Inoue S, Dimaano EM, Alera MT, Robles AM et al. Association of increased platelet associated immunoglobulins with thrombocytopenia and severity of disease in secondary dengue virus infections. Clin Exp Immunol 2004; 138: 299-303.
7. La Russa VF, Innis BL. Mechanism of dengue virus-induced bone marrow suppression. Bailliers Clin Hematol 1995; 8: 249-270.
8. Butthep P, Bunyaratvej A, Bhamarapravati N. Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1993; 24: 246-249.
9. Ascher DP, Laws HF, Hayes CG. The use of intravenous gammaglobulin in dengue fever, a case report. Southeast Asian J Trop Med Public Health 1989; 20: 549-554.
10. Schexneider KI, Reedy EA. Thrombocytopenia in dengue fever. Curr Hematol Rep 2005; 4: 145-148.